Page 312 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 312
Alcoholic Liver Disease and Drug Induced Liver Injury (Cont.)
P1110 ALCOHOL LIVER DISEASE IS MORE FREQUENT AND
MORE SEVERE THAN CHRONIC VIRAL HEPATITIS IN JAILS
OF A FRENCH DISTRICT
Corinne Bonny*, Géraldine Lamblin, Angeline Lenat-Guyot,
Cécile Henquell, Carine Nicolas, Sylviane Dydymski, Bruno Pereira,
Christine Jacomet, Armand Abergel, France
P1111 VARIABLES ASSOCIATED WITH ALCOHOL RELAPSE
AND PSYCHOSOCIAL INTERVENTIONS TO PREVENT
ALCOHOL RELAPSE IN LIVER TRANSPLANT PATIENTS FOR
ALCOHOLIC LIVER DISEASE: A SYSTEMATIC REVIEW
Iyoni Ranasinghe*, Ian Norman, Margaret Lau-Walker,
The United Kingdom
P1112 BACLOFEN: MAINTENANCE OF ABSTINENCE IN ALCOHOL
DEPENDENT PATIENTS ATTENDING LIVER CLINIC
Lynn Owens*, Abi Rose, Andrew Thompson, Munir Pirmohamed,
Ian Gilmore, Paul Richardson, The United Kingdom
ePOSTERS TOP 10% HUMAN KERATIN 8 VARIANTS PROMOTE MOUSE
YI P1113 ACETAMINOPHEN HEPATOTOXICITY COUPLED WITH JNK
ACTIVATION AND PROTEIN ADDUCT FORMATION
Nurdan Guldiken*, Qin Zhou, Ozlem Kucukoglu, Melanie Rehm,
Kateryna Levada, Laura P. James, Christian Trautwein, M. Bishr Omary,
Pavel Strnad, Germany
YI P1114 A METABOLOMICS APPROACH TO IDENTIFY
EXECRATORY METABOLITE SIGNATURE IN PATIENTS
WITH SEVERE ALCOHOLIC HEPATITIS NON RESPONSIVE
TO GLUCO-CORTICOSTEROID THERAPY
Jaswinder S. Maras*, Shvetank Sharma, Sukanta Das, Shasthry SM,
Shabir Hussain, Christophe Junot, Richard Moreau, Shiv K. Sarin, India
YI P1115 ERK AND P38 ACTIVATION ARE CENTRAL MEDIATORS OF
IRINOTECAN-INDUCED STEATOHEPATITIS
Abdo Mahli*, Michael Saugspier, Wolfgang Thasler, Martina Müller,
Anja Bosserhoff, Claus Hellerbrand, Germany
YI P1116 ARE MEGAMITOCHONDRIA A CELLULAR SURVIVAL
STRATEGY FOR ETHANOL-INDUCED LIVER TOXICITY?
Elena Palma*, Antonio Riva, Roger Williams, Shilpa Chokshi,
The United Kingdom
312 The International Liver Congress™ 2015 • ILC Programme
P1110 ALCOHOL LIVER DISEASE IS MORE FREQUENT AND
MORE SEVERE THAN CHRONIC VIRAL HEPATITIS IN JAILS
OF A FRENCH DISTRICT
Corinne Bonny*, Géraldine Lamblin, Angeline Lenat-Guyot,
Cécile Henquell, Carine Nicolas, Sylviane Dydymski, Bruno Pereira,
Christine Jacomet, Armand Abergel, France
P1111 VARIABLES ASSOCIATED WITH ALCOHOL RELAPSE
AND PSYCHOSOCIAL INTERVENTIONS TO PREVENT
ALCOHOL RELAPSE IN LIVER TRANSPLANT PATIENTS FOR
ALCOHOLIC LIVER DISEASE: A SYSTEMATIC REVIEW
Iyoni Ranasinghe*, Ian Norman, Margaret Lau-Walker,
The United Kingdom
P1112 BACLOFEN: MAINTENANCE OF ABSTINENCE IN ALCOHOL
DEPENDENT PATIENTS ATTENDING LIVER CLINIC
Lynn Owens*, Abi Rose, Andrew Thompson, Munir Pirmohamed,
Ian Gilmore, Paul Richardson, The United Kingdom
ePOSTERS TOP 10% HUMAN KERATIN 8 VARIANTS PROMOTE MOUSE
YI P1113 ACETAMINOPHEN HEPATOTOXICITY COUPLED WITH JNK
ACTIVATION AND PROTEIN ADDUCT FORMATION
Nurdan Guldiken*, Qin Zhou, Ozlem Kucukoglu, Melanie Rehm,
Kateryna Levada, Laura P. James, Christian Trautwein, M. Bishr Omary,
Pavel Strnad, Germany
YI P1114 A METABOLOMICS APPROACH TO IDENTIFY
EXECRATORY METABOLITE SIGNATURE IN PATIENTS
WITH SEVERE ALCOHOLIC HEPATITIS NON RESPONSIVE
TO GLUCO-CORTICOSTEROID THERAPY
Jaswinder S. Maras*, Shvetank Sharma, Sukanta Das, Shasthry SM,
Shabir Hussain, Christophe Junot, Richard Moreau, Shiv K. Sarin, India
YI P1115 ERK AND P38 ACTIVATION ARE CENTRAL MEDIATORS OF
IRINOTECAN-INDUCED STEATOHEPATITIS
Abdo Mahli*, Michael Saugspier, Wolfgang Thasler, Martina Müller,
Anja Bosserhoff, Claus Hellerbrand, Germany
YI P1116 ARE MEGAMITOCHONDRIA A CELLULAR SURVIVAL
STRATEGY FOR ETHANOL-INDUCED LIVER TOXICITY?
Elena Palma*, Antonio Riva, Roger Williams, Shilpa Chokshi,
The United Kingdom
312 The International Liver Congress™ 2015 • ILC Programme
